These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21703476)

  • 21. Technological and behavioral strategies to reduce treatment burden and improve adherence to inhaled antibiotics in cystic fibrosis.
    Geller DE; Madge S
    Respir Med; 2011 Dec; 105 Suppl 2():S24-31. PubMed ID: 22208547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of aerosolized antimicrobials in the treatment of ventilator-associated pneumonia.
    Dhand R
    Respir Care; 2007 Jul; 52(7):866-84. PubMed ID: 17594731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled antimicrobial therapy.
    O'Riordan T; Faris M
    Respir Care Clin N Am; 1999 Dec; 5(4):617-31. PubMed ID: 10565884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of inhaled antibacterials in hospital-acquired and ventilator-associated pneumonia.
    Lesho E
    Expert Rev Anti Infect Ther; 2005 Jun; 3(3):445-51. PubMed ID: 15954860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unorthodox long-term aerosolized ampicillin use for methicillin-susceptible Staphylococcus aureus lung infection in a cystic fibrosis patient.
    Máiz L; Lamas A; Fernández-Olmos A; Suárez L; Cantón R
    Pediatr Pulmonol; 2009 May; 44(5):512-5. PubMed ID: 19360847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aerosolized antibiotics for non-cystic fibrosis bronchiectasis.
    Rubin BK; Williams RW
    Respiration; 2014; 88(3):177-84. PubMed ID: 25171580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME
    Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of inhaled antibiotics in cystic fibrosis patients.
    Wunderlich P; Paul KD; Wehner J
    Acta Univ Carol Med (Praha); 1990; 36(1-4):34-6. PubMed ID: 2130713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aerosolized antibiotics to treat ventilator-associated pneumonia.
    Luyt CE; Combes A; Nieszkowska A; Trouillet JL; Chastre J
    Curr Opin Infect Dis; 2009 Apr; 22(2):154-8. PubMed ID: 19276883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respiratory infections: established therapy and its limitations.
    Grassi GG
    Clin Ther; 1985; 7 Suppl A():19-36. PubMed ID: 3907844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delivery of antibiotics to the respiratory tract: an update.
    Traini D; Young PM
    Expert Opin Drug Deliv; 2009 Sep; 6(9):897-905. PubMed ID: 19637984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antibiotic inhalation in cystic fibrosis. A review of the literature].
    Steinkamp G
    Monatsschr Kinderheilkd; 1991 Feb; 139(2):73-80. PubMed ID: 1903843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Administration of antibiotics via the respiratory tract as monotherapy for pneumonia.
    Falagas ME; Agrafiotis M; Athanassa Z; Siempos II
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):447-52. PubMed ID: 18662112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.
    Drobnic ME; Suñé P; Montoro JB; Ferrer A; Orriols R
    Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of biomarkers in low respiratory tract infections.
    Blasi F; Bocchino M; Di Marco F; Richeldi L; Aliberti S
    Eur J Intern Med; 2012 Jul; 23(5):429-35. PubMed ID: 22726371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aerosolized antibiotics for ventilator-associated pneumonia: lessons from experimental studies.
    Rouby JJ; Bouhemad B; Monsel A; Brisson H; Arbelot C; Lu Q;
    Anesthesiology; 2012 Dec; 117(6):1364-80. PubMed ID: 23135264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [How long the antibiotic treatment should be for pulmonary infections?].
    Murris-Espin M
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S83-10S84. PubMed ID: 17127974
    [No Abstract]   [Full Text] [Related]  

  • 38. Respiratory infection in noncystic fibrosis bronchiectasis.
    Zoumot Z; Wilson R
    Curr Opin Infect Dis; 2010 Apr; 23(2):165-70. PubMed ID: 19996746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel amikacin inhaled formulation for the treatment of lower respiratory tract infections.
    Antoniu S; Azoicai D
    Drugs Today (Barc); 2013 Nov; 49(11):683-92. PubMed ID: 24308015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibiotics in aerosols].
    Héritier F
    Rev Med Suisse Romande; 1996 May; 116(5):341-4. PubMed ID: 8693269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.